More than a dozen cancer drugs have been in shortage in recent months, putting patients, particularly women, at risk.
Author: Karen Weintraub, USA TODAY
Study identifies symptoms that distinguish long COVID ‒ an essential step toward much-needed treatment
Researchers can finally identify the symptoms of long COVID thanks to a study of 10,000 Americans. Here’s what that means for treatment.
From ‘science fiction’ to reality: Paralyzed man walks again thanks to brain and spine implants
The new research is the first to stimulate both the spinal cord and brain, allowing a man to control his leg movements naturally.
A new research effort takes aim at 8 rare diseases. It could revolutionize many more.
The new project, Bespoke Gene Therapy Consortium, hopes its work on 8 rare diseases will set the standard and framework to help thousands of others.
Study finds brain ‘signature’ for chronic pain, which could improve diagnosis, treatment
Arthritis and other sources of chronic pain has a fundamentally different brain signature than the acute pain of a stubbed toe, study finds.
Medical errors kill thousands of people each year. But are hospitals getting any safer?
The pandemic worsened patient safety, with Leapfrog’s new report showing increases in hospital-acquired infections. It’s not all bad news though.
Duchenne muscular dystrophy promises a bleak future. Gene therapy may change that.
The treatment of Duchenne’s is in the midst of a revolution, bringing hope to a disease that inevitably left boys in a wheelchair in their teens.
What foods should I avoid with diabetes? Advice on best diet plan from a nutrition expert.
Half of America is at risk for diabetes. Here’s a look at the best and worst foods you should eat if you’re trying to control or prevent diabetes.
Diabetes drug Mounjaro helped people lose 16% of weight, study finds
Tirzepatide, sold under the brand name Mounjaro from Eli Lilly, is not yet approved for weight loss, but likely will be later this year.
US should have attacked COVID like a foreign invasion, experts say. Have we learned any lessons?
A group of more than 30 experts has written a book that examines what went wrong in how the United States responded to the COVID-19 pandemic.